Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey

Puntos clave

• PET is an essential tool in diagnosing brain tumours, aiding in both treatment planning and monitoring.
• The survey collected data across various European institutions, highlighting discrepancies in PET availability.
• Assessment included feedback on clinical guidelines for PET use in brain tumour management within the EORTC framework.
• Findings indicate a need for standardization in PET application among brain tumour specialists across Europe.